Compile Data Set for Download or QSAR
maximum 50k data
Found 46 Enz. Inhib. hit(s) with all data for entry = 3370
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM397993(US10322108, Example 1)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398041(US10322108, Example 37)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM397995(US10322108, Example 2A)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398040(US10322108, Example 36)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398038(US10322108, Example 34)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398034(US10322108, Example 30)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398027(US10322108, Example 23)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398026(US10322108, Example 22B)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398025(US10322108, Example 22A)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398023(US10322108, Example 21A)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398020(US10322108, Example 19B)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398019(US10322108, Example 19A)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398014(US10322108, Example 16B)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398013(US10322108, Example 16A)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398012(US10322108, Example 15B)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398011(US10322108, Example 15A)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398008(US10322108, Example 12)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398006(US10322108, Example 10)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398005(US10322108, Example 9)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398004(US10322108, Example 8)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398003(US10322108, Example 7)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398002(US10322108, Example 6)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398001(US10322108, Example 5)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM397999(US10322108, Example 3)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398000(US10322108, Example 4)
Affinity DataIC50: <100nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398032(US10322108, Example 28)
Affinity DataIC50:  550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398024(US10322108, Example 21B)
Affinity DataIC50:  550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398021(US10322108, Example 20A)
Affinity DataIC50:  550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398022(US10322108, Example 20B)
Affinity DataIC50:  550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398039(US10322108, Example 35)
Affinity DataIC50:  550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398030(US10322108, Example 26)
Affinity DataIC50:  550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398029(US10322108, Example 25)
Affinity DataIC50:  550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398028(US10322108, Example 24)
Affinity DataIC50:  550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398010(US10322108, Example 14)
Affinity DataIC50:  550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398009(US10322108, Example 13)
Affinity DataIC50:  550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398016(US10322108, Example 17B)
Affinity DataIC50:  550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398007(US10322108, Example 11)
Affinity DataIC50:  550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398015(US10322108, Example 17A)
Affinity DataIC50:  550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM397996(US10322108, Example 2B)
Affinity DataIC50:  550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398033(US10322108, Example 29)
Affinity DataIC50:  550nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398035(US10322108, Example 31)
Affinity DataIC50:  5.50E+3nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398036(US10322108, Example 32)
Affinity DataIC50:  5.50E+3nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398037(US10322108, Example 33)
Affinity DataIC50:  5.50E+3nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398031(US10322108, Example 27)
Affinity DataIC50:  5.50E+3nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398018(US10322108, Example 18B)
Affinity DataIC50:  5.50E+3nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Beijing Hanmi Pharmaceutical

US Patent
LigandPNGBDBM398017(US10322108, Example 18A)
Affinity DataIC50:  5.50E+3nMAssay Description:The compounds of the present application can regulate (inhibit) the biological activity of the nuclear receptor RORγ, and the intensity of such ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent